Clinical Roundtable Forum 2020
Virtual Event: 8:45 am EST
10th December 2020
Clinical Roundtable Forum 2020
Advertisement
One conversation with the right person can unlock many opportunities and new ideas
Attend the only event dedicated to bringing delegates together to share best practice and develop solutions by taking part in up to 3 interactive roundtable discussions, from a choice of 12.
The Clinical Roundtable Forum offers a unique opportunity to come together with your peers in a virtual environment. Hosted by industry experts and each focused on a single issue, roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.
Our keynote panel on Patient Engagement and Diversity, led by Patricia Cornet (Lead Community Partnerships, Bristol Myers Squibb & Women of Color in Pharma Co-Founder), will open the event. Log in for 8.30am ET so as not to miss Patricia and her expert panellists!
David Larwood, CEO, Valley Fever Solutions, will give our closing keynote presentation and he will explore how to manage an agile protocol in the current climate, plus explore what the 2021 clinical trial landscape will look like.
Register and get access to all of the following:
- Make new connections with our facilitated networking opportunities
- Deep dive into key issues by joining one of several expert-led roundtables
- Hear from industry leading headline speakers with live keynote addresses
- Multiple subjects covered to encourage cross-industry learning and collaboration
Places are limited on each roundtable so register your interest today.
ALL AGENDA TIMINGS IN EASTERN TIME
A FANTASTIC NETWORK OF YOUR PEERS AND COLLEAGUES RIGHT AT A TAP OR CLICK OF A BUTTON
Simply register, login on the day and get ready to connect and learn. With the right network at your fingertips, catching up with your peers has never been so easy – even from a distance.
TESTIMONIALS
-
‘That was a superb day, it feels like we’ve been at a real, in person, conference!’ Worldwide Clinical Trials
-
‘A great event, I met more people than I do at an in-person event and I’ve got loads of follow ups’ Conversis
-
‘The whole setting is actually very well accomplished! Thanks again for the invitation!’ Apogenix AG

Francesco Spoto
IRT Manager,Novartis
Biography: Francesco Spoto – System Support and Information manager at Novartis, Basel (Switzerland). Life Science professional with vast experience in Engineering, IT and R&D projects for Pharma and Medical Device industries. In the recent years, he has been focusing more on the drug development domain with specific emphasis on IRT and global supply chain. In his current role, he works on creating value via optimization of the clinical system landscape and on early adoption of new technologies. Francesco is a blockchain enthusiast and a strong believer in the power of habits.
Session Details: View In Agenda

Gaurang Majmudar
Senior Director of Patient Centric Services,Marken
Biography: A high-performing entrepreneurial GLOBAL SENIOR DIRECTOR with an exceptional track record of developing added value and patient centric solutions globally for Specialty, Orphan and Biosimilar medicines from clinical trials to commercialisation. Demonstrated strong strategy and leadership skills with commercial focus, in marketing, business development, and change management roles, such as identification and purchasing of new businesses, by driving value that exceeds forecasts.
Session Details: View In Agenda

Abby Sener
Abby Sener Manager, Almac ONE,Almac Group
Biography: Abby Sener has B.A. from Juniata College in Marketing & Communication. She holds a PMP certification and has a background in project management. She has spent 9+ years with Almac and has experience in both the Clinical Supplies and IRT areas within the company. Her current role as the Manager of Almac ONE involves responsibility for harmonized delivery of clinical trials operating in the Almac ONE model, using both Almac Clinical Technologies and Almac Clinical Services.
Session Details: View In Agenda

Tom White
Head of Strategic Sourcing, CTS,Clinigen Group
Biography: With 11 years’ experience working in the pharmaceutical industry, Tom White has developed leading-edge expertise in comparator sourcing across various project management, sourcing, and business development roles. Amongst other accomplishments, Tom pioneered an onco-generic ‘on demand’ clinical supply model in direct response to the growing use of chemotherapy products in the clinical supplies industry. Tom currently leads the Strategic Sourcing team at Clinigen, which is responsible for managing and developing key supplier relationships, implementing and developing sourcing strategies, and providing market-leading comparator sourcing solutions.
Session Details: View In Agenda

Patricia Cornet
Group Director and Lead Community Partnerships,Bristol Myers Squibb, Women of Color in Pharma Co-Founder
Biography: Progressive change agent with deep expertise in leading high performing teams, delivering innovative business strategy, and creating advocacy models transforming the way patients gain access to treatments. Proven innovator and trusted business partner who solves complex business, patient, and physician problems. Global pharmaceutical leadership experience spanning clinical operations, medical affairs, and research. Highly reputable advisor in the following therapeutic areas: Cardiovascular, Oncology, Immunoscicence, and Virology. Notable for designing and implementing global, disruptive integrated recruitment engagement strategies. Diversity thought leader and community advocate with a focus on advancing the careers of women.
Session Details: KEYNOTE EXPERT PANEL 10-12-2020, 8:45 am View In Agenda

Alan Yeomans
Global Head, Regulatory Compliance,Viedoc
Biography: Alan Yeomans has worked with the development of computerised systems for 40 years as hardware designer, programmer, system architect, project manager and in a number of management roles including CTO and QM. Alan has been at Viedoc Technologies since late 2008, where he is responsible for Quality Assurance of their EDC vendor business. From 2008-2014 he was also responsible for Quality Assurance for their CRO business, until that part of the company was organised as a separate entity. Alan has earlier worked as CTO for a Swedish CRO (CDC) and as CTO and QM for an international ePRO provider (Clinitrac). Alan worked at British Aerospace, Space and Communications Division from 1981 to 1984 as a hardware designer on control systems for communications satellites. While there he developed the first CPU-board used in control systems on their communications satellites. After moving to Sweden in 1984 Alan started working with software development, starting with hardware driver routines and moving up through the software architecture to all levels, including user interface software and database software.
Session Details: View In Agenda

Dana Leff Niedzielska
CEO,August Research

Julie Martin
Director of Clinical Operations,Scimega
Biography: Julie Martin, M.Sc., MBA, Director, Clinical Operations, Scimega Research has developed an expertise in managing a wide array of oncology clinical trials set in early and late clinical development stages including collaborative efforts with larger CROs. At Scimega she is responsible for the strategic planning, conduct and oversight of oncology clinical trials across Canada, and for the development of project proposals. In addition, Mrs Martin serves as Director, Business Development, and is a member of Scimega’s managing Board of Directors. She received her Master of Science in Biochemistry from the University of Montreal and holds a Masters of Business Administration from Concordia University. Mrs. Martin is a member of the American Society of Clinical Oncology (ASCO) and the Society of Clinical Research Associates (SoCRA).
Session Details: View In Agenda

Iain Gordon
Chief Business Officer,EastHORN Clinical Services
Biography: Iain joined EastHORN in 2013 to play a key role in the next stages of EastHORN’s ambitious plans for growth. He has been managing CRO business development in Europe and North America for more than 15 years. Since the first tentative steps into Poland and Hungary in the 90’s he has enjoyed and been a key part of the spectacular growth in clinical services in this region and beyond. Senior management roles as European Head and Global VP of Business Development have enabled Iain to be at the leading edge of business and corporate development within the global CRO industry. Iain is based in the UK and graduated in Cell Biology from the University of Glasgow.
Session Details: View In Agenda

Barry Murphy
Director, Business Development,Novotech
Biography: Business Development professional with 10 years experience working in clinical research. Passionate about improving patient education and outcomes, boosting the industry reputation amongst the general public, increasing efficiency and quality in clinical trials and ultimately bringing more effective and safer treatment options to patients. Currently working for Novotech - a rapidly growing, fast paced and agile, full service CRO covering exclusively APAC with an aim to be the CRO of choice for the region.
Session Details: View In Agenda

Alyce King
Senior Business Development Manager,Novotech
Biography: Business Development professional with 10+ years experience working in Healthcare and Clinical Research. Established track record of closing complex multimillion dollar deals. Skilled in strategic relationship development, clinical research, prospecting, development of proposals, budgets and presentations, as well as contract negotiation and management. Strong communication, leadership and analytical skills with a BS in Chemistry and Human Physiology from Monash University. Currently working for Novotech - a rapidly growing, fast paced, full service CRO, covering the Asia Pacific region.
Session Details: View In Agenda

Neta Bendelac
Senior Director, Strategy,4G Clinical
Biography: Neta Bendelac, 4G Clinical Senior Director of Strategy, has over 10 years of experience in Clinical Supply Chain Management. She headed the Clinical Supply Chain department at Teva Pharmaceuticals, where she established new and innovative approaches to managing IMPs in clinical trials, designing them with a highly acclaimed and unique patient perspective. Prior to Teva, Neta worked as an international Supply Chain consultant, providing simulations and optimization tools to clients worldwide. Neta holds a BS in Industrial Engineering and a Master of Business Administration (MBA) from Tel Aviv University, Israel. Neta is always focused on execution, finding joy in creative solutions to help patients around the world.
Session Details: View In Agenda

Scott Schliebner
Senior Vice President, Center for Rare Diseases,PRA Health Sciences
Biography: Mr. Schliebner is a clinical strategist with a 25+ year background in clinical drug development focused on rare diseases, orphan drugs, and advanced therapeutics. He develops innovative solutions and strategic considerations to help overcome the operational, logistical, and ethical challenges inherent to conducting research in challenging patient populations. Mr. Schliebner’s efforts are focused on patient-centered approaches to drug development; reducing the burden of clinical trial participation; and leveraging virtual and de-centralized paradigms to bring new therapies to patients faster. Mr. Schliebner also serves as the Co-Chair of Global Genes’ Corporate Alliance, and serves on the Board of Uplifting Athletes. He holds a Master’s Degree in Public Health (MPH) from the University of Utah School of Medicine, and completed a Graduate Research Fellowship at The National Institutes of Health.
Session Details: View In Agenda

Irena Seredina
Executive Director,S-Clinica
Biography: Irena Seredina has medico-economic background. She graduated with honours as a medical doctor. When practicing as a medical doctor, she has carried out a doctoral research. Then, she received Master in Economics and studied management and marketing. Irena has more than 20 years of experience in clinical trials. At S-Clinica, Irena manages business development, partnerships and client relationship.
Session Details: View In Agenda

Lorena Kuri
WOCIP Director, Global Leadership; Head, Diversity Strategy, Bristol Myers Squibb ,
Biography: I am a people oriented, active and sensitive change agent leading the R&D efforts to help serve more Patients around the world. My international experience and transferable skills helped me change careers after more than 14 years in Commercial roles, finding a match in Clinical Operations, expanding the opportunity to help medically underserved populations. My business acumen and customer focus have been key to demonstrate results in different roles, but more importantly to engage with key stakeholders. I hold a Masters in Human Capital, and am fluent in Spanish, English and Portuguese. I believe in the value of connecting others and am proud of building this connections and helping whenever is needed. I am an inclusion advocate.
Session Details: KEYNOTE EXPERT PANEL 10-12-2020, 8:45 am View In Agenda

Kemi Olugemo
WOCIP Director of Communications; Executive Medical Director, Head Neurology Clinical Development, Akcea Therapeutics,
Biography: Physician-Executive with clinical experience and expertise in all phases of CNS drug development, global medical strategy, business development, and innovations in lifecycle planning.
Session Details: KEYNOTE EXPERT PANEL 10-12-2020, 8:45 am View In Agenda

Annie Harris
WOCIP Founding Member & Director of IT; Director, Technology Enablement, Covance,
Biography: Experienced Director Of Technology with a demonstrated history of working in the clinical development technology area. Strong professional in IT Strategy and System Business Process.
Session Details: KEYNOTE EXPERT PANEL 10-12-2020, 8:45 am View In Agenda

Vickie Laurent
WOCIP Board Member; Global Regulatory Affairs Lead, LEO Pharma,
Biography: Experienced leader within the pharmaceutical industry in the US and EU with demonstrated experience producing results in new drug development and drug approvals across global markets. Skilled driver of strategic Global Regulatory Affairs, Drug Development across multiple indications including Oncology, Hematology, Cardiovascular, medical Dermatology, across R&D and Commercial. Global and commercial minded with strong clinical/medical, business, P&L understanding and interpretation as well as ability to seamlessly transition between therapeutic areas, transversing comfortably between R&D, commercial, and cross regionally
Session Details: KEYNOTE EXPERT PANEL 10-12-2020, 8:45 am View In Agenda

Paul O'Donohoe
Scientific Lead, eCOA and Mobile Health,Medidata Solutions
Biography: Experienced health outcomes researcher with an expertise focused on technology driven data capture. Passionate about developing the science of COA and driving the industry forward within the burgeoning field of technologically supported outcomes in clinical trials through research, publications and presentations. Currently Scientific Lead, eCOA and Mobile Health at Medidata Solutions, a clinical software platform provider. I am responsible for developing the companys scientific expertise for electronic clinical outcome assessments and mobile health in clinical trials, and support internal teams and Sponsors around the implementation of industry and regulatory best practices in studies using eCOA and wearables. I am actively involvement in industry consortia such a C-Path ePRO Consortium, the Clinical Trial Transformation Initiative (CTTI) and the DIA Wearables Working Group.
Session Details: View In Agenda

Anne Bruns
Director, Clinical Patient Advocacy PTC Therapeutics,
Biography: Ms. Bruns is an experienced patient advocate, an influencer within the rare disease community and a former rare disease nonprofit leader. Using strategic and operational leadership, she provides synergy between Clinical Operations and Patient Advocacy with a focus on building the framework for pipeline assets. Her direct understanding of the unique needs of the rare community provide valuable insights to the innovation teams. Ms. Bruns’ dedication to supporting families and rare disease organizations ensure that patient perspective is included in all areas of drug development.
Session Details: View In Agenda

Veer Mehta
Founder Halo Health,
Biography: Veer Mehta is the founder and CEO at Halo Health Systems, a digital platform that accelerates clinical trials for pharma. With over 15 years of medical industry experience, he has extensive experience in the development & launch of FDA approved medical devices and digital health solutions. Veer has led engineering teams that have worked closely with large medical device and pharma companies, developing innovative technologies in the areas of endocrinology, cardiology, and immunology therapeutics. His passion for improving patient centricity in healthcare has led to an accomplished career in medical technologies, improving the lives of patients, clinicians, and researchers.
Session Details: View In Agenda

Kelly Koziol
Director of Client Services, 4G Clinical,

David Larwood
CEO,Valley Fever Solutions
Biography: David Larwood is a founder, the CEO, and chief chemist for Valley Fever Solutions, running the manufacturing process for a novel antifungal headed for Phase 2a trials in summer 2020. In his role as BD lead, he is responsible for many aspects of the company’s planning and operations. Valley Fever Solutions is a small startup working first on a new and improved treatment for Valley Fever (coccidioidomycosis). Their NikZ will transform the standard of care. Mr. Larwood co-invented his first two commercial molecules before age 30. His PhD research at UC San Francisco established the foundation for PEGylated drugs widely used today, where he co-invented suitable PEGylated lipids to make the very first PEGylated liposomes. As a bench chemist, he was the first to make Iotrolan, a CT contrast agent, now generic. Moving to law, he advised well known companies on patent matters, later moving to Apple Computer. Later, he took a VP role at startup FormFactor, staying in an IP role, then became the first General Counsel for startup Verisity Design, taking them public in 2001, then ultimately through acquisition in 2005. Mr. Larwood is the third of his family to be involved in Valley Fever. His father was a clinician who developed an interest in the disease decades ago when the family moved to Bakersfield, California, a focal area for the disease. His mother started a foundation in about 1998 and raised some $20M for research into vaccines against Valley Fever.
Session Details: CLOSING KEYNOTE: Establishing how best to position your study design to maintain an agile protocol in the current climate, plus exploring projections for 2021 10-12-2020, 1:45 pm View In Agenda
Sponsors












Viedoc
Sponsorship opportunities
To enquire about sponsorship opportunities for the conference, please contact:
Paul Adams
Sales Director – Healthcare
E: PaulAdams@arena-international.com
T: +44 (0)207 936 6948
Speaker Opportunities
To enquire about speaking opportunities for the conference, please contact:
Chloe Roberts
Head of Healthcare Events
E: Chloe.Roberts@arena-international.com
T: +44 (0) 207509 0470